Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-11-18

FDA Approved: REVATIO — Original Application (Viatris Specialty LLC)

View source ↗

Summary

The FDA approved Revatio (sildenafil citrate) via an original application by Viatris Specialty LLC for the treatment of pulmonary arterial hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • REVATIO (SILDENAFIL CITRATE)

Snippet

ORIG AP for REVATIO (SILDENAFIL CITRATE)